Correlation Between OUTLOOK THERAPEUTICS and Intellipharmaceutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OUTLOOK THERAPEUTICS and Intellipharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OUTLOOK THERAPEUTICS and Intellipharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OUTLOOK THERAPEUTICS INC and Intellipharmaceutics International, you can compare the effects of market volatilities on OUTLOOK THERAPEUTICS and Intellipharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OUTLOOK THERAPEUTICS with a short position of Intellipharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of OUTLOOK THERAPEUTICS and Intellipharmaceutics.

Diversification Opportunities for OUTLOOK THERAPEUTICS and Intellipharmaceutics

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between OUTLOOK and Intellipharmaceutics is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding OUTLOOK THERAPEUTICS INC and Intellipharmaceutics Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellipharmaceutics and OUTLOOK THERAPEUTICS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OUTLOOK THERAPEUTICS INC are associated (or correlated) with Intellipharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellipharmaceutics has no effect on the direction of OUTLOOK THERAPEUTICS i.e., OUTLOOK THERAPEUTICS and Intellipharmaceutics go up and down completely randomly.

Pair Corralation between OUTLOOK THERAPEUTICS and Intellipharmaceutics

Given the investment horizon of 90 days OUTLOOK THERAPEUTICS INC is expected to under-perform the Intellipharmaceutics. But the stock apears to be less risky and, when comparing its historical volatility, OUTLOOK THERAPEUTICS INC is 6.66 times less risky than Intellipharmaceutics. The stock trades about 0.0 of its potential returns per unit of risk. The Intellipharmaceutics International is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  7.00  in Intellipharmaceutics International on September 5, 2024 and sell it today you would lose (3.20) from holding Intellipharmaceutics International or give up 45.71% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy30.51%
ValuesDaily Returns

OUTLOOK THERAPEUTICS INC  vs.  Intellipharmaceutics Internati

 Performance 
       Timeline  
OUTLOOK THERAPEUTICS INC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OUTLOOK THERAPEUTICS INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Intellipharmaceutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Intellipharmaceutics International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward indicators, Intellipharmaceutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

OUTLOOK THERAPEUTICS and Intellipharmaceutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OUTLOOK THERAPEUTICS and Intellipharmaceutics

The main advantage of trading using opposite OUTLOOK THERAPEUTICS and Intellipharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OUTLOOK THERAPEUTICS position performs unexpectedly, Intellipharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellipharmaceutics will offset losses from the drop in Intellipharmaceutics' long position.
The idea behind OUTLOOK THERAPEUTICS INC and Intellipharmaceutics International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Correlations
Find global opportunities by holding instruments from different markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance